261 related articles for article (PubMed ID: 6319296)
41. Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells.
Harris RS; Croom-Carter DS; Rickinson AB; Neuberger MS
J Virol; 2001 Nov; 75(21):10488-92. PubMed ID: 11581418
[TBL] [Abstract][Full Text] [Related]
42. T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
[TBL] [Abstract][Full Text] [Related]
43. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
Klein G; Dombos L; Gothoskar B
Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
[No Abstract] [Full Text] [Related]
44. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
Giunta S; Groppa G
Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
[TBL] [Abstract][Full Text] [Related]
45. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
Daibata M; Speck SH; Mulder C; Sairenji T
Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
[TBL] [Abstract][Full Text] [Related]
47. A monoclonal antibody with anti-Burkitt lymphoma specificity. I. Analysis of human haematopoietic and lymphoid cell lines.
Wiels J; Lenoir GM; Fellous M; Lipinski M; Salomon JC; Tetaud C; Tursz T
Int J Cancer; 1982 Jun; 29(6):653-8. PubMed ID: 6286514
[TBL] [Abstract][Full Text] [Related]
48. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.
McCormick KH; Giovanella BC; Klein G; Nilsson K; Stehlin JS
Int J Cancer; 1981 Oct; 28(4):455-8. PubMed ID: 6273332
[TBL] [Abstract][Full Text] [Related]
49. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine.
Hampar B; Derge JG; Martos LM; Walker JL
Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012
[TBL] [Abstract][Full Text] [Related]
50. The detection of Epstein-Barr virus receptors utilizing radiolabelled virus.
Koide N; Wells A; Volsky DJ; Shapiro IM; Klein G
J Gen Virol; 1981 May; 54(Pt 1):191-5. PubMed ID: 6270245
[TBL] [Abstract][Full Text] [Related]
51. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin.
Shapiro IM; Luka J; Andersson-Anvret M; Klein G
Intervirology; 1979; 12(1):19-25. PubMed ID: 227812
[TBL] [Abstract][Full Text] [Related]
52. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
Kryworuckho M; Diaz-Mitoma F; Kumar A
Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
[TBL] [Abstract][Full Text] [Related]
53. Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures.
Avila-Cariño J; Torsteinsdottir S; Ehlin-Henriksson B; Lenoir G; Klein G; Klein E; Masucci MG
Int J Cancer; 1987 Nov; 40(5):691-7. PubMed ID: 2824386
[TBL] [Abstract][Full Text] [Related]
54. No evidence for differences in the Epstein-Barr virus genome carried in Burkitt lymphoma cells and nonmalignant lymphoblastoid cells from the same patients.
Bornkamm GW; von Knebel-Doeberitz M; Lenoir GM
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4930-4. PubMed ID: 6087353
[TBL] [Abstract][Full Text] [Related]
55. Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines.
Altiok A; Bejarano MT; Ruscetti F; Altiok E; Klein G; Klein E
Growth Factors; 1991; 4(2):117-28. PubMed ID: 1646619
[TBL] [Abstract][Full Text] [Related]
56. Hybridization between a human epithelial line, infectable by Epstein-Barr virus, and Burkitt lymphoma lines: membrane properties, superinfectability, inducibility and tumorigenicity.
Mitrani-Rosenbaum S; Ber R; Goldblum N; Povey S; Gamliel H; Ben-Bassat H
Int J Cancer; 1982 Nov; 30(5):593-600. PubMed ID: 6295967
[TBL] [Abstract][Full Text] [Related]
57. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.
Klein G; Lindahl T; Jondal M; Leibold W; Menézes J; Nilsson K; Sundström C
Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3283-6. PubMed ID: 4369887
[TBL] [Abstract][Full Text] [Related]
58. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis.
Phillips NE; Parker DC
J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594
[TBL] [Abstract][Full Text] [Related]
59. Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublines.
Spira G; Aman P; Koide N; Lundin G; Klein G; Hall K
J Immunol; 1981 Jan; 126(1):122-6. PubMed ID: 6256436
[TBL] [Abstract][Full Text] [Related]
60. Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines.
Nilsson K; Andersson LC; Gahmberg CG; Wigzell H
Int J Cancer; 1977 Nov; 20(5):708-16. PubMed ID: 200571
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
